An MRI Study of Basal Ganglia Volumes in First-Episode Schizophrenia Patients Treated With Risperidone

Abstract

This group of first-episode patients did not exhibit abnormalities of basal ganglia volumes, nor were basal ganglia volumes affected by exposure to risperidone. Movement disorders were observed in both first-episode and chronically treated patients, suggesting effects of both illness and medications.